代谢相关脂肪性肝病（MAFLD）综合管理策略研究进展

摘要/Abstract

摘要： 本文对代谢相关脂肪性肝病（MAFLD）综合管理的内容重点、综合管理的模式和理论工具应用进行综述,强调了高危人群的筛查和评估、以生活方式干预为基石的治疗在健康管理中的重要性,阐述“分级、分层、全程”“多学科、个体化”的管理模式,探讨目前阶段MAFLD综合健康管理中存在的不足,并作展望,为MAFLD的防治管理策略、分级诊疗和临床路径建立提供依据。

关键词: 代谢相关脂肪性肝病（MAFLD）, 综合管理

Abstract: This article reviews the focus of comprehensive management content of MAFLD, the mode of comprehensive management and the application of theoretical tools. It emphasizes the importance of screening and assessment of high-risk groups and treatment based on lifestyle intervention in health management, and expounds the management mode of “grading, stratification, whole process”, “multidisciplinary and individualized”. The article discussed the shortcomings in the comprehensive health management of MAFLD at the current stage, which may provide a basis for the prevention and management strategy, hierarchical diagnosis and treatment and clinical pathway establishment of MAFLD.

Key words: metabolism-related fatty liver disease (MAFLD), comprehensive management

中图分类号:

孙雨菁, 任文, 任菁菁. 代谢相关脂肪性肝病（MAFLD）综合管理策略研究进展[J]. 中华养生保健, 2023, 41(3): 52-55.

SUN Yu-jing, REN Wen, REN Jing-jing. Research Progress of Comprehensive Management Strategy for Metabolism-related Fatty Liver Disease (MAFLD)[J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(3): 52-55.

参考文献

[1] Eslam M, Sarin S K, Wong V W, et al.The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease[J]. Hepatology international,2020,14(6):889-919.
[2] 中国研究型医院学会肝病专业委员会,中国医师协会脂肪性肝病专家委员会,中华医学会肝病学分会脂肪肝与酒精性肝病学组,等.中国脂肪性肝病诊疗规范化的专家建议(2019年修订版)[J].现代医药卫生,2019,35(23):3728,后插1-后插4.
[3] 刘海霞,韩晓霞,孙敏,等.不同健康教育模式对院外非酒精性脂肪肝患者的干预效果[J].河南医学研究,2019,28(24):4424-4427.
[4] 高小莲,郑文清,肖明中,等.基于计划行为理论的中青年肥胖性非酒精性脂肪性肝病患者中医健康管理行为意向的结构方程模型分析[J].中国全科医学,2019,22(35):4362-4369.
[5] Vilar-Gomez E, Calzadilla-Bertot L, Wong V W S, et al. Fibrosis Severity as a Determinant of Cause-specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study[J]. Gastroenterology,2018,155(2):443-457,e17.
[6] Shah A G, Lydecker A, Murray K, et al.Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease[J]. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,2009,7(10):1104-1112.
[7] 范丹丹. 追踪随访联合医护一体化护理干预对非酒精性脂肪肝患者健康行为及生活质量的影响[J].黑龙江医药科学,2019,42(3):245-246,248.
[8] Angulo P, Hui J M, Marchesini G, et al.The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD[J]. Hepatology (Baltimore, Md),2007,45(4):846-854.
[9] Angulo P, Bugianesi E, Bjornsson E S, et al. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease [J]. Gastroenterology,2013,145(4):782-9.e4.
[10] Vallet-Pichard A, Mallet V, Nalpas B, et al.FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest[J]. Hepatology (Baltimore, Md),2007,46(1):32-36.
[11] Sterling R K, Lissen E, Clumeck N, et al.Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection[J]. Hepatology (Baltimore, Md),2006,43(6):1317-1325.
[12] Costa-Silval L, Ferolla S M, Lima A S, et al.MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease[J]. European journal of radiology,2018,98:82-89.
[13] 夏幼辰. 非酒精性脂肪性肝炎无创性评估方法研究进展[J].西南医科大学学报,2020,43(2):102-106.
[14] Herrmann E, D E Lédinghen V, Cassinotto C, et al. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis[J]. Hepatology (Baltimore, Md),2018,67(1):260-272.
[15] Chalasani N, Younossi Z, Lavine J E, et al.The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases[J]. Hepatology (Baltimore, Md),2018,67(1):328-357.
[16] 肖倩倩,王梦雨,范建高.亚太肝病研究学会代谢相关脂肪性肝病临床诊疗指南(治疗部分)简介[J].临床肝胆病杂志,2021,37(1):41-45.
[17] 张伟,施军平.创建MAFLD防治新模式,合力推进分层全程管理[J].实用肝脏病杂志,2020,23(5):609-611.
[18] 李东宇,陈莞婧,刘玉萍.非酒精性脂肪性肝病健康管理模式的思考与实践[J].中华健康管理学杂志,2019,13(1):81-83.
[19] 程艳然. 基于计划行为理论的非酒精性脂肪性肝病患者中医健康管理行为意向研究[D].武汉:湖北中医药大学,2019.